Last updated at 05 Jul 2024 09:11 AM
Director
DIN: 06605571
Anurag Agarwal is currently associated with 2 companies as Director. They serve as a Director at SHREE MARUTI NANDAN PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06605571.Anurag Agarwal has previously been associated with 1 company in roles such as Additional Director.Anurag Agarwal is currently involved in 1 different role. Their most recent position is with D N S BUILDERS PRIVATE LIMITED as a Director. The first company Anurag Agarwal was appointed to as a director was SHREE MARUTI NANDAN PHARMACEUTICALS PRIVATE LIMITED. Anurag Agarwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Anurag Agarwal is currently associated with 2 companies as Director. They serve as a Director at SHREE MARUTI NANDAN PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06605571.Anurag Agarwal has previously been associated with 1 company in roles such as Additional Director.Anurag Agarwal is currently involved in 1 different role. Their most recent position is with D N S BUILDERS PRIVATE LIMITED as a Director. The first company Anurag Agarwal was appointed to as a director was SHREE MARUTI NANDAN PHARMACEUTICALS PRIVATE LIMITED. Anurag Agarwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
2y 6m 1y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SHREE MARUTI NANDAN PHARMACEUTICALS PRIVATE LIMITED | Director | 11-Oct-2013 |
| D N S BUILDERS PRIVATE LIMITED | Director | 29-Jan-2014 |